期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

撤离免疫抑制剂联合白细胞介素2治疗同种异基因造血干细胞移植后白血病复发患者临床疗效观察 被引量：2

原文传递
导出
摘要 异基因造血干细胞移植（allo-HSCT）是当今治疗白血病的最有效手段，但移植后白血病复发严重影响其疗效，对allo-HSCT复发患者当前最有效的方法之一是供者淋巴细胞输注（DLI），但对于非血缘关系供者移植复发患者因受供者来源的限制，不能使所有患者受益。我们报道7例allo-HSCT复发患者采用免疫抑制剂停用或减量，给予IL-2方案治疗，取得较好的疗效，现报道如下。
作者 宁涓 刘启发 罗晓丹 范志平 张钰 孙竞
机构地区 南方医科大学南方医院血液科
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第7期480-481,共2页 Chinese Journal of Hematology
关键词 异基因造血干细胞移植 白血病复发 免疫抑制剂 疗效观察 方案治疗 白细胞介素2 ALLO-HSCT
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献6

  • 1孙敬芬,韩晓苹,赵丹丹,汪菲菲,靳海杰,高春记,达万明,于力.STR-PCR分析嵌合体在同种异基因造血干细胞移植中的应用[J].中国实验血液学杂志,2007,15(2):337-341. 被引量：10
  • 2Dazzi F, Fozza C. Disease replase after haematopoietic stem cell transplantation:risk factors and treatmen. Best Pract Clin Haematol, 2007,20:311-327.
  • 3Prinz E, Keil F, Kalhs P, et al. Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation. Ann Hematol,2003, 82 : 295-298.
  • 4Elmaagacli AH, Beelen DW, Trenn G, et al. Induction of a graftversus-leukemia reaction by cyclosporln A withdrawal as immunotherapy for leukemia relapsing after allogcncic bone marrow transplantation. Bone Marrow Transplant, 1999,23:771-777.
  • 5Soiffer RJ, Murray C, Gonin R, et al. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood, 1994, 84:964-971.
  • 6DeAngelo DJ, Hochberg EP, Alyea EP, et al. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation : durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease. Clin Cancer Res, 2004, 10: 5065-5071.

二级参考文献12

  • 1李素霞,达万明,高春记,朱海燕,王书红,薄剑,靖彧,靳海杰.STR-PCR对造血干细胞移植后植入证据的检测[J].中国实验血液学杂志,2005,13(1):25-29. 被引量：6
  • 2Bader P,Klingebiel T,Schaudt A,et al.Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixedchimerism:a single center experience of 12 children.Leukemia,1999;13:2079-2086
  • 3Dubovsky J,Daxberger H,Fritsch G,et al.Kinetics of chimerism during the early post -transplant period in pediatric patients with malignant and non-malignant hematologic disorders:implication for timely detection of engraftment,graft failure and rejection.Leukemia,1999; 13:2059,2060-2069
  • 4Thiede C,Florek M,Bornhauser M,et al.Rapid quantification mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescene detection.Bone Marrow Transplant,1999;23:1055-1059
  • 5Nollet F,Billiet J,Selleslag D,et al.Standardisation of multiplex fluorescent short tandem repeat analysis for chime-rism testing.Bone Marrow Transplant,2001; 28:511-518
  • 6Bader P,Holle W,Klingebiel T,et al.Mixed hematopoietic chimerism after allogeneic bone marrow transplantation:the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.Bone Marrow Transplanat,1997; 19:697 -702
  • 7Sykes M.Mixed chimerism and transplant tolerance.Immunity,2001; 14:417 -424
  • 8Antin JH,Childs R,Filipovich AH,et al.Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantations:recommendations from a workshop at the 2001 Tandem Meeting of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.Biol Blood Marrow Transplant,2001; 7:473-485
  • 9Thiede C,Bornhauser M,Oelschlagel U,et al.Seqential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers.Leukemia,2001; 15:293-302
  • 10Chalandon Y,Vischer S,Helg,C,et al.Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection:the Geneva experience.Leukemia,2003; 17:228-231

共引文献9

同被引文献10

  • 1黄晓军,刘代红.造血干细胞移植在白血病治疗中的地位[J].新医学,2004,35(7):399-400. 被引量：3
  • 2Murphy WJ, Koh CY, Raziuddin A, et al. Immunobiology of natural killer cells and bone marrow transplantatin: merging of basic and preclinical studies. Immunol Rev, 2001,181:279-289.
  • 3Soiffer RJ, Murray C, Gonin R, et al. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood, 1994,84:964-971.
  • 4Maloney DG,Molia AJ,Sahebi F,et al.Allografting with nonmyeloablative conditioning following cytoreductive autografts for treatment of patients with multiple myeloma[J].Blood,2003,102(9):3447-3454.
  • 5Gale RP,Horowitz MM,Weiner RS,et al.Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission[J].Bome Marrow Transplantation,1995,16:203-208.
  • 6Urbano-Ispizua A,Rozman C,Pimentel P,et al.The number of donor CD3^+ cells is the most important factor for graft failure after allogeneic thansplantation of CD34^+ selected cells from peripheral blood from HLA-identical siblings[J].Blood,2001,97:383-387.
  • 7Harousseau JL,Cahn JY,Pignon L,et al.Comparison of autologours bome marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia[J].Blood,1997,90:2978-2986.
  • 8Hillard ML,Waleska SP,John PK,et al.Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia:a retrospective amalysis from the Cente for International Blood and Marrow Transplant Research[J].Br J Heamatol,2005,132(6):775-769.
  • 9Soiffer RJ,Murray C,Gonin R,et al.Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation[J].Blood,1994,84:964-971.
  • 10陈广华,吴德沛,孙爱宁,杨明珍,王易,唐晓文,常惠荣,冯宇峰,朱子玲.IL-2和IL-15激活供者自然杀伤细胞在异基因造血干细胞移植应用的实验研究[J].中华血液学杂志,2008,29(8):526-530. 被引量：5

引证文献2

中华血液学杂志
2008年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部